Together Pharma Ltd (TLV:TGTR)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
204.00
-2.70 (-1.31%)
Sep 3, 2026, 11:08 AM IDT

Together Pharma Balance Sheet

Millions ILS. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
5.4512.228.443.595.35.1
Cash & Short-Term Investments
5.4512.228.443.595.35.1
Cash Growth
-42.99%44.71%135.08%-32.17%3.94%-11.51%
Accounts Receivable
24.8714.9616.9912.638.350.91
Other Receivables
3.62.322.550.440.090.22
Receivables
28.4717.2919.5413.068.441.13
Inventory
65.8763.2456.3855.2644.5946.53
Prepaid Expenses
-1.270.140.370.990.41
Other Current Assets
---0.45-34.08
Total Current Assets
99.7994.0184.572.7459.3187.24
Property, Plant & Equipment
30.9433.0635.4735.4436.5934.8
Long-Term Investments
----0.1-
Goodwill
16.1816.1816.1816.1816.1816.18
Other Intangible Assets
6.38.248.541215.4318.43
Other Long-Term Assets
2.422.492.372.22.22
Total Assets
155.63153.98147.05138.55129.79158.65

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
22.1617.9421.3613.769.366.21
Accrued Expenses
-6.354.556.825.122.92
Short-Term Debt
34.4328.3727.4811.8915.596.21
Current Portion of Long-Term Debt
5.64.041417.356.0939.69
Current Portion of Leases
1.481.481.481.561.40.62
Current Unearned Revenue
-----0.3
Other Current Liabilities
15.6913.139.9510.849.7710.24
Total Current Liabilities
79.3671.378.8262.2247.3266.19
Long-Term Debt
11.7715.119.7313.3125.9729.77
Long-Term Leases
10.0810.7510.8710.6911.029.08
Pension & Post-Retirement Benefits
-----0.04
Long-Term Deferred Tax Liabilities
4.94.83.453.99--
Other Long-Term Liabilities
0.861.895.9750.8842.4527.86
Total Liabilities
106.97103.84108.84141.1126.77132.94

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
251.76251.76239.76194.62197.39183.96
Retained Earnings
-212.67-211.23-213.14-211.97-207.65-174.13
Comprehensive Income & Other
7.257.496.79.569.8310.79
Total Common Equity
46.3448.0333.32-7.79-0.4320.63
Minority Interest
2.322.114.895.243.455.08
Shareholders' Equity
48.6650.1438.21-2.553.0225.71
Total Liabilities & Equity
155.63153.98147.05138.55129.79158.65

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
63.3659.7563.5754.860.0885.37
Net Cash (Debt)
-57.9-47.53-55.12-51.21-54.78-80.27
Net Cash Growth
------
Net Cash Per Share
-3.34-3.01-4.44-5.83-6.72-11.72
Filing Date Shares Outstanding
17.3517.3513.818.798.797.53
Total Common Shares Outstanding
17.3517.3513.818.798.797.43
Working Capital
20.4422.715.6810.5111.9921.05
Book Value Per Share
2.672.772.41-0.89-0.052.78
Tangible Book Value
23.8723.618.61-35.97-32.03-13.98
Tangible Book Value Per Share
1.381.360.62-4.09-3.65-1.88
Machinery
-20.6619.418.1617.3317
Leasehold Improvements
-13.8615.4114.5314.2213.11